Home > Income Statement > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
Revenue

    Back to Income Statement
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

BALAXI PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹241 Cr₹336 Cr₹279 Cr₹231 Cr₹46 Cr

What is the latest Revenue of BALAXI PHARMACEUTICALS ?

The latest Revenue ratio of BALAXI PHARMACEUTICALS is ₹241 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹241 Cr
Mar2024₹336 Cr
Mar2023₹279 Cr
Mar2022₹231 Cr
Mar2021₹46 Cr

How is Revenue of BALAXI PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2025 ₹241 Cr
-28.28
Mar2024 ₹336 Cr
20.42
Mar2023 ₹279 Cr
20.77
Mar2022 ₹231 Cr
406.94
Mar2021 ₹46 Cr -

Compare Revenue of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹121.7 Cr -4.3% -12.2% -67.6% Stock Analytics
ADANI ENTERPRISES ₹288,837.0 Cr -0.1% 2.9% -1.2% Stock Analytics
REDINGTON ₹21,021.9 Cr 0.6% -0.1% 25.9% Stock Analytics
MMTC ₹9,931.5 Cr 4.7% 4.3% -3% Stock Analytics
HONASA CONSUMER ₹9,517.1 Cr 4% 1.9% 32.2% Stock Analytics
LLOYDS ENTERPRISES ₹8,860.1 Cr -6.4% -4.9% 23.1% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

-4.3%

-12.2%

-67.6%

SENSEX

0.5%

0.8%

7.2%


You may also like the below Video Courses